| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/08/2001 | CA2380407A1 Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses |
| 02/08/2001 | CA2380295A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
| 02/08/2001 | CA2380108A1 Recombinant rsv virus expression systems and vaccines |
| 02/08/2001 | CA2380018A1 Immunotherapy in hiv infected persons using vaccines after multi-drug treatment |
| 02/08/2001 | CA2379832A1 Invasive bacteria-based viral vaccines |
| 02/08/2001 | CA2379703A1 Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses |
| 02/08/2001 | CA2379538A1 Personal care articles |
| 02/08/2001 | CA2379360A1 Human g-protein coupled receptor |
| 02/08/2001 | CA2378929A1 Serine proteases |
| 02/08/2001 | CA2378864A1 Rotavirus vaccine formulations |
| 02/08/2001 | CA2378432A1 Proteins and peptides |
| 02/08/2001 | CA2374743A1 Human chaperone proteins |
| 02/08/2001 | CA2374383A1 Oxazolidinones and their use as antiinfectives |
| 02/08/2001 | CA2362785A1 Glucamine compounds for treating hepatitis virus infections |
| 02/07/2001 | EP1074625A2 DNA vaccine against feline immunodeficiency virus |
| 02/07/2001 | EP1074623A1 ABC transporter |
| 02/07/2001 | EP1074614A1 A recombinant Newcastle disease virus for in ovo vaccination |
| 02/07/2001 | EP1074559A1 Peptide nucleic acids |
| 02/07/2001 | EP1074556A1 Phosphonic diester derivatives |
| 02/07/2001 | EP1074554A2 7-acyl-3-(substituted carbamoyloxy) cephem compounds, use thereof and process for their preparation |
| 02/07/2001 | EP1074553A1 7-Acyl-3-(substituted carbamoyloxy) cephem compounds, use thereof and process for their preparation |
| 02/07/2001 | EP1074266A2 Live attenuated bacteria for use in a vaccine |
| 02/07/2001 | EP1074248A1 Delivery system for biological material |
| 02/07/2001 | EP1073759A1 Recombinant virus expressing foreign dna encoding feline cd80, feline cd28, feline ctla-4 or feline cd86 and uses thereof |
| 02/07/2001 | EP1073758A1 Retroviral vectors including modified envelope escort proteins |
| 02/07/2001 | EP1073750A1 Preparation of human papillomavirus e1 having helicase activity and method therefor |
| 02/07/2001 | EP1073749A2 Enhancing immune responses to genetic immunization by using a chemokine |
| 02/07/2001 | EP1073748A2 Vaccines containing recombinant pilin against neisseria gonorrhoeae or neisseria meningitidis |
| 02/07/2001 | EP1073745A2 Immunization against and treatment for infection by h. pylori |
| 02/07/2001 | EP1073741A2 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 02/07/2001 | EP1073740A1 Polynucleotides isolated from skin cells and methods for their use |
| 02/07/2001 | EP1073735A1 Host-encoded protein expressed on marek's disease virus (mdv)-infected cells and antibody thereto |
| 02/07/2001 | EP1073713A1 6-phosphogluconate dehydrogenase of streptococcus pneumoniae |
| 02/07/2001 | EP1073681A1 Cloning of a novel 7tm receptor axor-2 |
| 02/07/2001 | EP1073677A1 STAPHYLOCOCCUS AUREUS pyrH POLYPEPTIDES AND POLYNUCLEOTIDES |
| 02/07/2001 | EP1073672A1 Antipicornaviral compounds, their preparation and use |
| 02/07/2001 | EP1073669A2 Gcp |
| 02/07/2001 | EP1073667A2 Polysaccharide-antigen conjugates |
| 02/07/2001 | EP1073662A1 Process for preparing (-)pyridobenzoxazine carboxylic acid derivatives |
| 02/07/2001 | EP1073655A1 Pharmaceutically available protoberberine salts derivatives, and protoberberine derivatives and salts thereof |
| 02/07/2001 | EP1073637A1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases |
| 02/07/2001 | EP1073471A1 Method of treating endotoxemia |
| 02/07/2001 | EP1073469A1 Stable mitoxantron solutions |
| 02/07/2001 | EP1073462A2 Hepatitis vaccine |
| 02/07/2001 | EP1073461A1 Viral chimeras comprised of caev and hiv-1 genetic elements |
| 02/07/2001 | EP1073460A1 Nucleic acid encoding hyaluronan synthase and methods of use |
| 02/07/2001 | EP1073458A1 Chlamydia proteins and their uses |
| 02/07/2001 | EP1073447A1 N1-modified glycopeptides |
| 02/07/2001 | EP1073436A1 IMPROVED METHOD FOR ERADICATION OF $i(HELICOBACTER PYLORI) |
| 02/07/2001 | EP1073415A1 Pharmaceutical compositions capable of being gelled |
| 02/07/2001 | EP1073414A1 Use of pharmaceutical compositions capable of being gelled in periodontology |
| 02/07/2001 | EP1043318A4 Salts of 5,5'-arylidenebisbarbituric and 5,5'-arylidenebis(2-thiobarbituric) acids and 5,5'-arylidenebis(2-thiobarbituric) acids having an antibacterial, anti-chlamydial, antiviral and immuno-modulating activity |
| 02/07/2001 | EP0652771B1 Tetanus vaccine production |
| 02/07/2001 | CN1283199A Z-halo-6-o-substituted ketolide derivatives |
| 02/07/2001 | CN1283197A Pleuromutilin derivatives as antimicrobials |
| 02/07/2001 | CN1283188A Bisulfate salt of HIV protease inhibitor |
| 02/07/2001 | CN1283183A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 02/07/2001 | CN1283121A HIV-ITAT or derwatives thereof for prophylatic and therapeutic vacceination |
| 02/07/2001 | CN1283117A Orally administrable solid ribavirin dosafe forms and process for making them |
| 02/07/2001 | CN1283108A I (chlamydia) protein, gene sequence and uses thereof |
| 02/07/2001 | CN1282612A Antituberculotic aerosol composition and its preparing process |
| 02/07/2001 | CN1282592A Plaster for treating bone diseases |
| 02/07/2001 | CN1282583A Exterior-applied ointment |
| 02/07/2001 | CN1061557C Capsule of ginkgo and garlic extracts |
| 02/06/2001 | US6184393 Pyronin antibacterials, process and novel intermediates thereto |
| 02/06/2001 | US6184371 Lactoferrin receptor genes of Moraxella |
| 02/06/2001 | US6184369 Anti-viral guanosine-rich oligonucleotides |
| 02/06/2001 | US6184368 Polyvalent carbohydrate molecules |
| 02/06/2001 | US6184366 Substituted liposaccharides useful in the treatment and prevention of endotoxemia |
| 02/06/2001 | US6184244 C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/06/2001 | US6184237 Substituted pyridine compounds and methods of use |
| 02/06/2001 | US6184230 Administering orally a quinolone antibiotic comprising 1-hydroxy-2-(2-trans-nonenyl)-3-methyl-4(1h)-quinolone or salt to treat gastrointestinal disorders, lymphomas, chronic heart disease |
| 02/06/2001 | US6184223 Reverse-turn mimetics and methods relating thereto |
| 02/06/2001 | US6184025 Nucleotide sequences for the detection and diagnosis of viral diseases |
| 02/06/2001 | US6183986 OspA DNA and lyme disease vaccine |
| 02/06/2001 | US6183949 HCV peptide antigens and methods for the determination of HCV |
| 02/06/2001 | US6183775 Buccal delivery system |
| 02/06/2001 | US6183753 Recombinant chimeric virus and uses thereof |
| 02/06/2001 | US6183751 Unique associated Kaposi's Sarcoma virus sequences and uses thereof |
| 02/06/2001 | US6183750 Vaccines; gene expression |
| 02/06/2001 | US6183746 Administering vaccine; gene expression; urogenital disorders, anticarcinogenic agents |
| 02/06/2001 | US6183745 Subunit papilloma virus vaccine and peptides for use therein |
| 02/06/2001 | CA2213798C Method for stimulating an immune response |
| 02/06/2001 | CA2163032C Antibody fragments in therapy |
| 02/06/2001 | CA2126118C 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative |
| 02/06/2001 | CA2106299C Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 02/05/2001 | CA2309313A1 Stimulation of the immune response by human dendritic cell manipulation |
| 02/01/2001 | WO2001007658A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | WO2001007651A2 Transposon mediated differential hybridisation |
| 02/01/2001 | WO2001007643A1 Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating the drug effect of antimicrobial agent, and antimicrobial agents |
| 02/01/2001 | WO2001007637A2 Conditionally controlled, attenuated hiv vaccine |
| 02/01/2001 | WO2001007628A2 Human synthetases |
| 02/01/2001 | WO2001007625A2 Ehrlichia canis genes and vaccines |
| 02/01/2001 | WO2001007612A2 Receptors and associated proteins |
| 02/01/2001 | WO2001007471A2 Cell cycle and proliferation proteins |
| 02/01/2001 | WO2001007470A2 Human nervous system-associated proteins |
| 02/01/2001 | WO2001007469A2 Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs |
| 02/01/2001 | WO2001007468A2 Novel cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical |
| 02/01/2001 | WO2001007467A1 Streptogramin derivatives, preparation and compositions containing same |
| 02/01/2001 | WO2001007459A1 29 human secreted proteins |